UniProt A0A142IX72
NS3 protease (A0A142IX72)
NS3 protease (UniProt A0A142IX72), EC 3.4.21.91, 3.6.1.15: 29 experimental structures on GenesisL1, 16 ligands bound, 33 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- A0A142IX72
- Protein
- NS3 protease
- EC
- 3.4.21.91, 3.6.1.15, 3.6.4.13
- Experimental structures
- 29
- Predicted models
- 0
- Ligands
- 16
- Pockets
- 33 · 3 records with a druggable one
Structures
29 records of A0A142IX72 in the MolNFT archive: 29 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 5GJ4 | Structure of NS2B-NS3 Protease from Zika Virus caught after self-cleavage | x-ray diffraction | A, B, C, D, E, F, G, H | CL | 9 (best 0.48) |
| 5GJ4 | Structure of NS2B-NS3 protease from zika virus caught after self- cleavage | x-ray diffraction | A, B, C, D, E, F, G, H | — | — |
| 5ZOB | Crystal structure of Zika NS3 protease with 4-guanidinomethyl-phenylacetyl-Arg-Arg-Arg-4-amidinobenz… | x-ray diffraction | B, D, H, F | — | — |
| 5ZOB | Crystal structure of zika NS3 protease with 4-guanidinomethyl… | x-ray diffraction | B, D, H, F | 2UE, 00S | — |
| 6JPW | Crystal structure of Zika NS2B-NS3 protease with compound 1C | x-ray diffraction | B, D, F, H | — | 5 (best 0.62) |
| 6JPW | Crystal structure of zika NS2B-NS3 protease with compound 1C | x-ray diffraction | B, D, F, H | C0F | — |
| 6KK2 | Crystal structure of Zika NS2B-NS3 protease with compound 2 | x-ray diffraction | B | D9U | 1 (best 0.44) |
| 6KK2 | Crystal structure of zika NS2B-NS3 protease with compound 2 | x-ray diffraction | B | D9U | — |
| 6KK3 | Crystal structure of Zika NS2B-NS3 protease with compound 4 | x-ray diffraction | B | DUU | 1 (best 0.41) |
| 6KK3 | Crystal structure of zika NS2B-NS3 protease with compound 4 | x-ray diffraction | B | DUU | — |
| 6KK4 | Crystal structure of Zika NS2B-NS3 protease with compound 9 | x-ray diffraction | B | DE0 | — |
| 6KK4 | Crystal structure of zika NS2B-NS3 protease with compound 9 | x-ray diffraction | B | DE0 | — |
| 6KK5 | Crystal structure of Zika NS2B-NS3 protease with compound 15 | x-ray diffraction | B | DE6 | — |
| 6KK5 | Crystal structure of zika NS2B-NS3 protease with compound 15 | x-ray diffraction | B | DE6 | — |
| 6KK6 | Crystal structure of Zika NS2B-NS3 protease with compound 16 | x-ray diffraction | B | SO4, DV0 | — |
| 6KK6 | Crystal structure of zika NS2B-NS3 protease with compound 16 | x-ray diffraction | B | SO4, DV0 | — |
| 6KPQ | Crystal structure of Zika NS2B-NS3 protease with compound 8 | x-ray diffraction | B | DT0 | 1 (best 0.43) |
| 6KPQ | Crystal structure of zika NS2B-NS3 protease with compound 8 | x-ray diffraction | B | DT0 | — |
| 6L50 | Crystal structure of Zika NS2B-NS3 protease with compound 16 | x-ray diffraction | B, D, F, H | E60 | 6 (best 0.64) |
| 6L50 | Crystal structure of zika NS2B-NS3 protease with compound 16 | x-ray diffraction | B, D, F, H | E60 | — |
| 7DOC | Crystal structure of Zika NS2B-NS3 protease with compound 5 | x-ray diffraction | B, D, F | — | 6 (best 0.67) |
| 7DOC | Crystal structure of zika NS2B-NS3 protease with compound 5 | x-ray diffraction | B, D, F | HHC | — |
| 7VLG | Crystal structure of Zika NS2B-NS3 protease with compound MI2201 | x-ray diffraction | B | 7PZ | 1 (best 0.39) |
| 7VLG | Crystal structure of zika NS2B-NS3 protease with compound MI2201 | x-ray diffraction | B | 7PZ | — |
| 7VLH | Crystal structure of Zika NS2B-NS3 protease with compound MI2219 | x-ray diffraction | B | 7Q3, SO4 | 1 (best 0.44) |
| 7VLH | Crystal structure of zika NS2B-NS3 protease with compound MI2219 | x-ray diffraction | B | 7Q3, SO4 | — |
| 7VLI | Crystal structure of Zika NS2B-NS3 protease with compound MI2220 | x-ray diffraction | B | 7QG, SO4 | 1 (best 0.40) |
| 7VLI | Crystal structure of zika NS2B-NS3 protease with compound MI2220 | x-ray diffraction | B | 7QG, SO4 | — |
| 8PN6 | Crystal Structure of co-expressed NS2B-NS3 Protease from Zika Virus | x-ray diffraction | B | — | 1 (best 0.41) |
Ligands
- SO4 · Sulfate ion · in 6 records
- 7PZ · 1-[(5~{R},8~{R},15~{S},18~{S})-15,18-bis(4-azanylbutyl)-4,7,14,17,20-pentakis(oxidanylidene)-5-propan-2-yl-3,6,13,16,19-pentazabicyclo[20.3.1]hexacosa-1(25),22(26),23-trien-8-yl]guanidine · in 2 records
- 7Q3 · 1-[(3~{S},6~{R},18~{R})-3,6-bis(4-azanylbutyl)-2,5,8, 11,14,17-hexakis(oxidanylidene)-1,4,7,10,13,16-hexazacyclodocos-18-yl]guanidine · in 2 records
- 7QG · 1-[(3~{S},6~{S},19~{R})-3,6-bis(4-azanylbutyl)-2,5,8, 12,15,18-hexakis(oxidanylidene)-1,4,7,11,14,17-hexazacyclotricos-19-yl]guanidine · in 2 records
- D9U · 1-[(10~{S},17~{S},20~{S})-17,20-bis(4-azanylbutyl)-4,9, 16,19,22-pentakis(oxidanylidene)-3,8,15,18,21-pentazabicyclo[22.2.2]octacosa-1(27),24(28),25-trien-10-yl]guanidine · in 2 records
- DE0 · 1-[(9~{R},16~{S},19~{S})-16,19-bis(4-azanylbutyl)-4,8, 15,18,21-pentakis(oxidanylidene)-3,7,14,17,20-pentazabicyclo[21.3.1]heptacosa-1(26),23(27),24-trien-9-yl]guanidine · in 2 records
- DE6 · 1-[(5~{S},8~{R},15~{S},18~{S})-15,18-bis(4-azanylbutyl)-5-methyl-4,7,14,17,20-pentakis(oxidanylidene)-3,6,13,16,19-pentazabicyclo[20.3.1]hexacosa-1(25),22(26),23-trien-8-yl]guanidine · in 2 records
- DT0 · 1-[(10~{R},17~{S},20~{S})-17,20-bis(4-azanylbutyl)-4,9, 16,19,22-pentakis(oxidanylidene)-3,8,15,18,21-pentazabicyclo[22.3.1]octacosa-1(27),24(28),25-trien-10-yl]guanidine · in 2 records
- DUU · 1-[(10~{R},17~{S},20~{S})-17,20-bis(4-azanylbutyl)-4,9, 16,19,22-pentakis(oxidanylidene)-3,8,15,18,21-pentazabicyclo[22.2.2]octacosa-1(26),24,27-trien-10-yl]guanidine · in 2 records
- DV0 · 1-[(5~{R},8~{R},15~{S},18~{S})-15,18-bis(4-azanylbutyl)-5-methyl-4,7,14,17,20-pentakis(oxidanylidene)-3,6,13,16,19-pentazabicyclo[20.3.1]hexacosa-1(25),22(26),23-trien-8-yl]guanidine · in 2 records
- E60 · 2-sulfanylidene-1,3-thiazolidin-4-one · in 2 records
- 00S · 4-(aminomethyl)benzenecarboximidamide · in 1 record
- 2UE · 1-[4-(2-oxoethyl)benzyl]guanidine · in 1 record
- C0F · (4~{R})-2-[4-[(2~{S})-2,3-bis(azanyl)-3-oxidanylidene-propyl]pyridin-2-yl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid · in 1 record
- CL · Chloride ion · in 1 record
- HHC · ~{N}-[(2~{R})-2,3-bis(azanyl)-3-oxidanylidene-propyl]-2-[(4~{R})-4-methanoyl-4,5-dihydro-1,3-thiazol-2-yl]pyridine-4-carboxamide · in 1 record
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.